Q32 Bio Inc.
QTTB
- Revenue · TTM
- $53.7MFour comparable prior quarters required for growth
- Gross profit · TTM
- $53.4MFour comparable prior quarters required for growth99.3% margin
- Operating income · TTM
- $21.4MFour comparable prior quarters required for growth39.8% margin
- Free cash flow · TTM
- $-27.4MFour comparable prior quarters required for growth-51.0% margin
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Operating metrics
The measures behind the business.
No operating metrics are currently published for this company.
Revenue mix
What the company sells, and where.
No revenue breakdown is currently published for this company.
Income statement
From revenue to profit.
Cash flow
Cash generated and cash spent.
Balance sheet
What the company owns and what it owes.
Financial statements
Every published field, with exact amounts and disclosure sources.
View full financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 53,737,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | -14,662,000USD |
| Cost Of Revenue | 90,000USD | 90,000USD | 91,000USD | 91,000USD | 119,000USD | 120,000USD | 121,000USD | 124,000USD |
| Gross Profit | -90,000USD | 53,647,000USD | -91,000USD | -91,000USD | -119,000USD | -120,000USD | -121,000USD | -14,662,000USD |
| Research Development | 3,218,000USD | 3,315,000USD | 3,555,000USD | 5,161,000USD | 7,124,000USD | 10,545,000USD | 13,411,000USD | 8,339,000USD |
| Selling General Administrative | 4,504,000USD | 4,543,000USD | 4,022,000USD | 4,010,000USD | 5,104,000USD | 3,981,000USD | 4,508,000USD | 2,808,000USD |
| Total Operating Expenses | 7,632,000USD | 7,768,000USD | 7,577,000USD | 9,080,000USD | 12,228,000USD | 14,526,000USD | 17,798,000USD | 11,147,000USD |
| Operating Income | -7,722,000USD | 45,879,000USD | -7,577,000USD | -9,171,000USD | -12,228,000USD | -14,526,000USD | -17,919,000USD | -25,809,000USD |
| Interest Expense | 200,000USD | 200,000USD | 300,000USD | 300,000USD | 300,000USD | — | 1,700,000USD | — |
| Income Before Tax | -7,609,000USD | 57,730,000USD | -7,389,000USD | -9,489,000USD | -11,031,000USD | -14,168,000USD | -15,529,000USD | -26,814,000USD |
| Net Income | -7,609,000USD | 57,730,000USD | -7,389,000USD | -9,489,000USD | -11,031,000USD | -14,189,000USD | -16,978,000USD | -27,067,000USD |
| Net Income From Continuing Ops | -7,609,000USD | 57,730,000USD | -7,389,000USD | -9,489,000USD | -11,031,000USD | -14,189,000USD | -16,978,000USD | 1,029,000USD |
| Ebit | -7,722,000USD | 45,789,000USD | -7,089,000USD | -9,189,000USD | -10,731,000USD | 6,589,000USD | -17,919,000USD | -25,809,000USD |
| Ebitda | -7,632,000USD | 45,879,000USD | -6,998,000USD | -9,098,000USD | -10,612,000USD | 6,709,000USD | -17,798,000USD | -25,685,000USD |
| Depreciation And Amortization | 90,000USD | 90,000USD | 91,000USD | 91,000USD | 119,000USD | 120,000USD | 121,000USD | 124,000USD |
| Reconciled Depreciation | 90,000USD | 90,000USD | 91,000USD | 91,000USD | 119,000USD | 120,000USD | 121,000USD | 123,000USD |
| Total Other Income Expense Net | 113,000USD | 11,851,000USD | 188,000USD | -318,000USD | 1,197,000USD | 358,000USD | 2,390,000USD | -1,005,000USD |
| Interest Income | — | 400,000USD | 500,000USD | 600,000USD | 700,000USD | — | — | — |
| Net Interest Income | — | 200,000USD | 200,000USD | 300,000USD | 400,000USD | — | — | — |
| Tax Provision | — | — | — | 0USD | 0USD | 21,000USD | 0USD | 253,000USD |
| Income Tax Expense | — | — | — | — | — | 21,000USD | 1,449,000USD | 253,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 121,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 53,737,000USD | 0USD | -6,651,000USD | 6,651,000USD | — | — |
| Cost Of Revenue | 391,000USD | 487,000USD | 499,000USD | 2,599,000USD | 684,214USD | 239,797USD |
| Gross Profit | 53,346,000USD | -487,000USD | -6,651,000USD | 6,651,000USD | -684,214USD | -239,797USD |
| Research Development | 19,156,000USD | 48,143,000USD | 31,729,000USD | 35,814,000USD | 21,378,154USD | 5,694,997USD |
| Selling General Administrative | 17,679,000USD | 17,959,000USD | 9,875,000USD | 10,062,000USD | — | — |
| Total Operating Expenses | 36,444,000USD | 65,614,999USD | 41,604,000USD | 45,876,000USD | 28,973,284USD | 9,760,221USD |
| Operating Income | 16,902,000USD | -66,102,000USD | -48,255,000USD | -39,225,000USD | -29,657,500USD | -10,000,020USD |
| Interest Income | 2,200,000USD | 3,900,000USD | — | — | — | — |
| Interest Expense | 1,100,000USD | 300,000USD | 1,500,000USD | — | — | — |
| Net Interest Income | 1,100,000USD | 2,800,000USD | — | — | — | — |
| Income Before Tax | 29,821,000USD | -47,712,000USD | -53,425,000USD | -42,747,000USD | -29,990,863USD | -8,046,817USD |
| Tax Provision | 0USD | 21,000USD | 318,000USD | 62,000USD | — | — |
| Net Income | 29,821,000USD | -47,733,000USD | -53,743,000USD | -42,809,000USD | -29,990,863USD | -8,046,817USD |
| Net Income From Continuing Ops | 29,821,000USD | -47,733,000USD | -53,743,000USD | -42,809,000USD | — | — |
| Ebit | 30,921,000USD | -45,787,000USD | -48,255,000USD | -39,225,000USD | -29,990,863USD | -8,046,817USD |
| Ebitda | 31,312,000USD | -45,300,000USD | -47,756,000USD | -38,855,000USD | -29,306,649USD | -7,807,020USD |
| Depreciation And Amortization | 391,000USD | 487,000USD | 499,000USD | 370,000USD | 684,214USD | 239,797USD |
| Reconciled Depreciation | 391,000USD | 487,000USD | 499,000USD | 370,000USD | — | — |
| Total Other Income Expense Net | 12,919,000USD | 18,390,000USD | -5,170,000USD | -3,522,000USD | -333,365USD | 1,953,201USD |
| Income Tax Expense | — | 21,000USD | 318,000USD | 62,000USD | -4USD | 2USD |
| Unclassified Operating Expenses | — | — | — | — | 7,595,130USD | 4,065,224USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 115,867,000USD | 63,675,000USD | 61,776,000USD | 57,784,000USD | 66,117,000USD | 79,071,000USD | 92,332,000USD | 104,542,000USD |
| Cash And Equivalents | 106,270,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 109,646,000USD | 57,202,000USD | 55,050,000USD | 50,810,000USD | 58,324,000USD | 68,632,000USD | 81,877,000USD | 93,898,000USD |
| Other Current Assets | 3,376,000USD | 1,059,000USD | 6,753,000USD | 1,215,000USD | 2,937,000USD | 2,594,000USD | 3,357,000USD | 4,257,000USD |
| Total Liabilities | 9,962,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,401,000USD | 10,669,000USD | 11,346,000USD | 11,110,000USD | 11,534,000USD | 14,579,000USD | 16,465,000USD | 14,383,000USD |
| Total Stockholder Equity | 105,905,000USD | 46,313,000USD | 42,014,000USD | -18,448,000USD | -12,235,000USD | -4,014,000USD | 5,675,000USD | 18,295,000USD |
| Total Equity Including Noncontrolling Interest | 105,905,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 5,574,000USD | 5,826,000USD | 6,079,000USD | 6,327,000USD | 6,576,000USD | 6,822,000USD | 7,092,000USD | 7,357,000USD |
| Accounts Payable | 1,565,000USD | 653,000USD | 879,000USD | 973,000USD | 910,000USD | 2,712,000USD | 2,989,000USD | 1,258,000USD |
| Common Stock | 3,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -221,548,000USD | -212,602,000USD | -204,993,000USD | -262,723,000USD | -255,334,000USD | -245,845,000USD | -234,814,000USD | -220,625,000USD |
| Total Liab | — | 17,362,000USD | 19,762,000USD | 76,232,000USD | 78,352,000USD | 83,085,000USD | 86,657,000USD | 86,247,000USD |
| Other Current Liab | — | 3,063,000USD | 4,232,000USD | 3,234,000USD | 3,745,000USD | 6,574,000USD | 9,767,000USD | 10,529,000USD |
| Capital Stock | — | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Cash | — | 50,751,000USD | 48,297,000USD | 49,039,000USD | 54,832,000USD | 65,483,000USD | 77,965,000USD | 89,078,000USD |
| Cash And Short Term Investments | — | 50,751,000USD | 48,297,000USD | 49,039,000USD | 54,832,000USD | 65,483,000USD | 77,965,000USD | 89,078,000USD |
| Net Debt | — | -37,105,000USD | -37,119,000USD | -32,014,000USD | -36,135,000USD | -46,684,000USD | -59,064,000USD | -69,654,000USD |
| Short Term Debt | — | 6,953,000USD | 6,235,000USD | 6,903,000USD | 6,879,000USD | 5,293,000USD | 3,709,000USD | 2,560,000USD |
| Short Long Term Debt | — | 6,239,000USD | 6,235,000USD | 6,232,000USD | 6,228,000USD | 4,662,000USD | 3,097,000USD | 1,533,000USD |
| Short Long Term Debt Total | — | 13,646,000USD | 11,178,000USD | 17,025,000USD | 18,697,000USD | 18,799,000USD | 18,901,000USD | 19,424,000USD |
| Long Term Debt | — | 1,939,000USD | 3,473,000USD | 5,001,000USD | 6,522,000USD | 8,039,000USD | 9,556,000USD | 11,071,000USD |
| Net Receivables | — | 5,392,000USD | — | 556,000USD | 555,000USD | 555,000USD | 555,000USD | 563,000USD |
| Property Plant Equipment Gross | — | 7,760,000USD | 7,923,000USD | 8,081,000USD | 8,239,000USD | 8,394,000USD | 8,545,000USD | 8,690,000USD |
| Common Stock Shares Outstanding | — | 14,095,371shares | 12,592,543shares | 12,240,542shares | 12,197,615shares | 12,197,615shares | 12,197,615shares | 12,076,412shares |
| Non Current Assets Total | — | 6,473,000USD | 6,726,000USD | 6,974,000USD | 7,793,000USD | 10,439,000USD | 10,455,000USD | 10,644,000USD |
| Non Current Liabilities Total | — | 6,693,000USD | 8,416,000USD | 65,122,000USD | 66,818,000USD | 68,506,000USD | 70,192,000USD | 71,864,000USD |
| Non Currrent Assets Other | — | 647,000USD | 647,000USD | 647,000USD | 570,000USD | 1,091,000USD | 763,000USD | 687,000USD |
| Net Working Capital | — | 46,533,000USD | 43,704,000USD | 39,700,000USD | 46,790,000USD | 54,053,000USD | 65,412,000USD | 79,515,000USD |
| Unclassified Current Liabilities | — | -6,239,000USD | -6,235,000USD | -6,232,000USD | -6,228,000USD | -4,662,000USD | -3,097,000USD | -1,497,000USD |
| Unclassified Non Current Liabilities | — | 4,754,000USD | 4,943,000USD | 5,121,000USD | 5,296,000USD | 5,467,000USD | 5,636,000USD | 5,793,000USD |
| Unclassified Equity | — | 258,911,000USD | 247,003,000USD | 244,271,000USD | 243,095,000USD | 241,827,000USD | 240,485,000USD | 238,917,000USD |
| Long Term Investments | — | — | 0USD | 0USD | 0USD | 2,526,000USD | 2,600,000USD | 2,600,000USD |
| Non Current Liabilities Other | — | — | — | 55,000,000USD | 55,000,000USD | 55,000,000USD | 55,000,000USD | 55,000,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | -1,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 61,776,000USD | 92,332,000USD | 47,057,000USD | 61,774,000USD | 211,721,000USD | 263,737,000USD | 310,567,000USD |
| Other Current Assets | 6,753,000USD | 3,357,000USD | 2,344,000USD | 146,000USD | 36,036,000USD | 1,733,000USD | 3,789,000USD |
| Total Liab | 19,762,000USD | 86,657,000USD | 229,978,000USD | 192,486,000USD | 42,070,000USD | 67,742,000USD | 52,060,000USD |
| Total Stockholder Equity | 42,014,000USD | 5,675,000USD | -182,921,000USD | 177,978,000USD | 169,651,000USD | 195,995,000USD | 258,507,000USD |
| Other Current Liab | 3,539,000USD | 9,767,000USD | 8,909,000USD | 8,456,000USD | 11,406,000USD | 9,803,000USD | 8,957,000USD |
| Common Stock | 2,000USD | 2,000USD | 1,000USD | 6,000USD | 6,000USD | 5,000USD | 4,000USD |
| Capital Stock | 2,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD | — | — |
| Retained Earnings | -204,993,000USD | -234,814,000USD | -187,081,000USD | -429,137,000USD | -424,132,000USD | -328,368,000USD | -199,674,000USD |
| Cash | 48,297,000USD | 77,965,000USD | 25,617,000USD | 43,893,000USD | 108,382,000USD | 217,431,000USD | 53,774,000USD |
| Cash And Short Term Investments | 48,297,000USD | 77,965,000USD | 25,617,000USD | 43,893,000USD | 155,873,000USD | 217,431,000USD | 262,388,000USD |
| Total Current Assets | 55,050,000USD | 81,877,000USD | 28,716,000USD | 46,853,000USD | 191,909,000USD | 219,564,000USD | 266,577,000USD |
| Total Current Liabilities | 11,346,000USD | 16,465,000USD | 14,109,000USD | 57,865,000USD | 17,226,000USD | 22,658,000USD | 12,374,000USD |
| Net Debt | -32,953,000USD | -59,064,000USD | 25,223,000USD | 838,000USD | -84,448,000USD | -201,989,000USD | -53,774,000USD |
| Short Term Debt | 6,928,000USD | 3,709,000USD | 1,416,000USD | 32,873,000USD | 246,000USD | 2,501,000USD | — |
| Short Long Term Debt | 6,235,000USD | 3,097,000USD | 878,000USD | 32,402,000USD | — | — | — |
| Short Long Term Debt Total | 15,344,000USD | 18,901,000USD | 50,840,000USD | 44,731,000USD | 23,934,000USD | 15,442,000USD | — |
| Long Term Debt | 3,473,000USD | 9,556,000USD | 43,176,000USD | 5,072,000USD | 4,972,000USD | — | — |
| Long Term Investments | 0USD | 2,600,000USD | 0USD | — | — | — | — |
| Accounts Payable | 879,000USD | 2,989,000USD | 3,468,000USD | 1,435,000USD | 2,366,000USD | 4,722,000USD | 2,608,000USD |
| Property Plant Equipment Net | 6,079,000USD | 7,092,000USD | 8,083,000USD | 9,166,000USD | 17,859,000USD | 42,899,000USD | 42,716,000USD |
| Property Plant Equipment Gross | 7,923,000USD | 8,545,000USD | 9,049,000USD | 9,633,000USD | 305,000USD | — | — |
| Common Stock Shares Outstanding | 12,314,796shares | 12,197,615shares | 3,218,626shares | 3,188,875shares | 3,071,295shares | 2,550,599shares | 2,339,871shares |
| Non Current Assets Total | 6,726,000USD | 10,455,000USD | 18,341,000USD | 14,921,000USD | 19,812,000USD | 44,173,000USD | 43,990,000USD |
| Non Current Liabilities Total | 8,416,000USD | 70,192,000USD | 215,869,000USD | 134,621,000USD | 24,844,000USD | 45,084,000USD | 39,686,000USD |
| Non Currrent Assets Other | 647,000USD | 763,000USD | 10,258,000USD | -20,059,000USD | -1,003,000USD | — | — |
| Net Working Capital | 43,704,000USD | 65,412,000USD | 14,607,000USD | -11,012,000USD | 26,782,000USD | — | — |
| Unclassified Current Liabilities | -6,235,000USD | -3,097,000USD | — | -31,832,000USD | — | — | — |
| Unclassified Non Current Liabilities | 4,943,000USD | 5,636,000USD | 117,693,000USD | 129,549,000USD | 19,144,000USD | 45,084,000USD | 39,686,000USD |
| Unclassified Equity | 247,003,000USD | 240,485,000USD | 4,163,000USD | 607,512,000USD | 593,783,000USD | 524,358,000USD | 457,994,000USD |
| Net Receivables | — | 555,000USD | 755,000USD | 1,064,000USD | 909,000USD | 400,000USD | 400,000USD |
| Non Current Liabilities Other | — | 55,000,000USD | 55,000,000USD | — | 728,000USD | — | — |
| Short Term Investments | — | — | 43,387,000USD | 141,040,000USD | 47,491,000USD | — | 208,614,000USD |
| Accumulated Other Comprehensive Income | — | — | -5,000USD | -404,000USD | -7,000USD | — | 183,000USD |
| Unclassified Current Assets | — | — | -43,387,000USD | -141,040,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | 14,531,000USD | 3,208,000USD | 5,632,000USD | 809,000USD |
| Inventory | — | — | — | 1,750,000USD | 769,000USD | — | 1USD |
| Unclassified Non Current Assets | — | — | — | 5,755,000USD | 1,953,000USD | 1,274,000USD | 1,274,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,609,000USD | 57,730,000USD | -7,389,000USD | -9,489,000USD | -11,031,000USD | -14,189,000USD | -17,595,000USD | -16,978,000USD |
| Depreciation | 33,000USD | 90,000USD | 91,000USD | 91,000USD | 119,000USD | 120,000USD | 123,000USD | 121,000USD |
| Stock Based Compensation | 1,548,000USD | 1,469,000USD | 1,176,000USD | 1,268,000USD | 1,342,000USD | 1,251,000USD | 1,382,000USD | 1,336,000USD |
| Other Non Cash Items | 253,000USD | -65,279,000USD | 204,000USD | 790,000USD | -687,000USD | 416,000USD | -153,000USD | 63,000USD |
| Change In Working Capital | -568,000USD | -190,000USD | 1,688,000USD | -3,311,000USD | -2,225,000USD | 974,000USD | -3,279,000USD | -6,756,000USD |
| Total Cash From Operating Activities | -6,343,000USD | -6,180,000USD | -4,230,000USD | -10,651,000USD | -12,482,000USD | -11,428,000USD | -19,522,000USD | -22,214,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -2,000USD | 0USD | -2,000USD | -58,000USD | -15,000USD |
| Free Cash Flow | -6,343,000USD | -6,180,000USD | -4,230,000USD | -10,651,000USD | -12,482,000USD | -11,430,000USD | -19,580,000USD | -22,229,000USD |
| Net Borrowings | -1,563,000USD | -1,562,000USD | -1,563,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 8,797,000USD | -1,562,000USD | -1,563,000USD | -317,000USD | 0USD | 317,000USD | 997,000USD | -5,522,000USD |
| Issuance Of Capital Stock | 10,360,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | 2,454,000USD | -742,000USD | -5,793,000USD | -10,651,000USD | -12,482,000USD | -11,113,000USD | -8,583,000USD | -17,848,000USD |
| Begin Period Cash Flow | 48,944,000USD | 49,686,000USD | 54,832,000USD | 66,130,000USD | 78,612,000USD | 89,725,000USD | 98,308,000USD | 116,156,000USD |
| End Period Cash Flow | 51,398,000USD | 48,944,000USD | 49,039,000USD | 55,479,000USD | 66,130,000USD | 78,612,000USD | 89,725,000USD | 98,308,000USD |
| Other Cashflows From Financing Activities | 8,797,000USD | — | — | -317,000USD | — | 317,000USD | 997,000USD | -5,522,000USD |
| Unclassified Financing Cash Flow | -8,797,000USD | — | — | — | — | — | — | — |
| Investments | — | 0USD | 0USD | 0USD | 0USD | -2,000USD | 9,942,000USD | 9,888,000USD |
| Total Cashflows From Investing Activities | — | 7,000,000USD | — | 2,000USD | — | -2,000USD | 9,942,000USD | 9,888,000USD |
| Other Cashflows From Investing Activities | — | 7,000,000USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | 29,821,000USD | -47,733,000USD | -53,743,000USD | -42,809,000USD | -95,764,000USD | -128,693,999USD | -103,916,000USD |
| Depreciation | 391,000USD | 487,000USD | 499,000USD | 370,000USD | 9,544,000USD | 8,904,000USD | 6,318,000USD |
| Stock Based Compensation | 5,255,000USD | 4,386,000USD | 1,428,000USD | 1,238,000USD | 753,000USD | — | — |
| Other Non Cash Items | -64,972,000USD | -15,218,000USD | 6,824,000USD | 876,000USD | 18,272,000USD | 13,937,999USD | 5,777,000USD |
| Change In Working Capital | -4,038,000USD | -9,637,000USD | 26,315,000USD | 26,943,000USD | -41,803,000USD | 11,520,000USD | 463,000USD |
| Total Cash From Operating Activities | -33,543,000USD | -67,715,000USD | -18,677,000USD | -10,957,000USD | -109,751,000USD | -94,332,000USD | -91,358,000USD |
| Capital Expenditures | -2,000USD | -75,000USD | -5,000USD | -2,485,000USD | -2,396,000USD | -3,733,000USD | -21,833,000USD |
| Free Cash Flow | -33,543,000USD | -67,790,000USD | -18,682,000USD | -13,442,000USD | -112,147,000USD | -98,065,000USD | -113,191,000USD |
| Investments | 0USD | 19,925,000USD | -5,000USD | -2,466,000USD | -157,000USD | — | — |
| Total Cashflows From Investing Activities | 7,000,000USD | 19,925,000USD | -5,000USD | -2,466,000USD | -50,788,000USD | 204,896,000USD | -51,799,000USD |
| Net Borrowings | -3,125,000USD | 7,000,000USD | 300,000USD | 30,000,000USD | 0USD | — | — |
| Total Cash From Financing Activities | -3,125,000USD | 95,138,000USD | 406,000USD | 30,069,000USD | 52,169,000USD | 53,093,000USD | 158,213,000USD |
| Issuance Of Capital Stock | 0USD | 42,000,000USD | 0USD | 69,000USD | 20,105,000USD | — | — |
| Change In Cash | -29,668,000USD | 47,348,000USD | -8,369,000USD | 16,646,000USD | -109,049,000USD | 163,657,000USD | 15,554,000USD |
| Begin Period Cash Flow | 78,612,000USD | 31,264,000USD | 33,986,000USD | 32,894,000USD | 217,431,000USD | 53,774,000USD | 38,220,000USD |
| End Period Cash Flow | 48,944,000USD | 78,612,000USD | 25,617,000USD | 49,540,000USD | 108,382,000USD | 217,431,000USD | 53,774,000USD |
| Other Cashflows From Investing Activities | 7,000,000USD | — | 554,000USD | -37,982,000USD | 48,392,000USD | — | — |
| Other Cashflows From Financing Activities | -3,125,000USD | 46,138,000USD | 101,326,000USD | -2,466,000USD | 52,054,000USD | 204,896,000USD | -51,799,000USD |
| Unclassified Financing Cash Flow | 3,125,000USD | — | -101,220,000USD | 2,466,000USD | -19,990,000USD | -151,803,000USD | 210,012,000USD |
| Unclassified Operating Cash Flow | — | — | — | 2,425,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | 40,467,000USD | -96,627,000USD | 208,629,000USD | -29,966,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. TTM requires four complete quarters. Missing values are not zero. Charts use rounded labels; expand values and sources for exact amounts. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.